EPS for Prelude Therapeutics Incorporated (PRLD)

Prelude Therapeutics Incorporated has an EPS of $-2.44. In 2021, the company made an earnings per share (EPS) of $-2.43. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.